Displaying 1-10 of 10 result(s).
| Board Name | Posts By Bake | Post Created |
|---|---|---|
| PTOI Plastic2Oil, Inc. | So you cannot attack the argument, | 07/29/2014 7:08:10 PM |
| PTOI Plastic2Oil, Inc. | No, but it answers clearly that the | 07/29/2014 7:04:24 PM |
| PTOI Plastic2Oil, Inc. | No need to take it up with anyone, | 07/29/2014 6:58:05 PM |
| PTOI Plastic2Oil, Inc. | No actually he didnt, comparing to | 07/29/2014 6:47:31 PM |
| PTOI Plastic2Oil, Inc. | Actually he didnt, he tried to brus | 07/29/2014 6:24:46 PM |
| THRA Therma-Med Inc | That is correct but who care if onl | 04/07/2012 3:57:03 PM |
| THRA Therma-Med Inc | Yet the very next day the DTC suspe | 04/07/2012 3:55:33 PM |
| THRA Therma-Med Inc | Incorrect, a lock has no effect on | 04/07/2012 3:35:44 PM |
| THRA Therma-Med Inc | No I did not miss that fact, and be | 04/07/2012 3:23:22 PM |
| THRA Therma-Med Inc | It is in a Global lock, so it canno | 04/07/2012 12:49:12 PM |
Recent Articles
- Understanding Key Economic Strategies from China's Leadership Meeting
- Financière de Tubize Announces Annual Dividend Distribution
- Celebrating Cinema at the 20th China Film Huabiao Awards
- Movado Group Faces SEC Scrutiny, Rosen Law Firm Steps In
- Experience the Thrill of Japan Open Poker Tour 2025
- A.I.S. Resources Completes Successful Private Placement Initiative
- Ready Capital Shareholder Legal Updates: Know Your Rights
- Investors Urged to Act: Lawsuits Filed Against e.l.f. Beauty
- Understanding Your Rights as a Bancorp Investor in Legal Matters
- Important Update for Viatris Investors: Legal Action Insights
- AppLovin Investors Reminded of Important Class Action Deadline
- Investors Have a Deadline to Join NET Power Class Action
- Fluence Energy Class Action Update: Important Deadline Approaches
- AppLovin Corporation Faces Shareholder Class Action Opportunities
- Formosa Pharmaceuticals Partners With Saval For New Eye Treatment
- Antengene Showcases Innovative Therapeutics at AACR Event
- 51Talk Online Education Group Releases Key Annual Report for 2024
- Skye Bioscience Unveils Stock Option Grant for New Employee
- Innovent Celebrates NMPA Approval of Limertinib for Lung Cancer Treatment
- Willow Biosciences Reveals Results from Recent Shareholder Meeting
- Investigation into Bitfarms Ltd: What Investors Should Know
- Investigation into HealthEquity, Inc. Sparks Investor Interest
- Creative Science Expands Horizons with Astaria Global Acquisition
- Investors Encouraged to Join Canopy Growth Class Action Suit
- Rosen Law Firm Initiates Investigation for Bitfarms Investors
- Agnico Eagle's 2025 Shareholder Meeting: Directors Elected
- Orbia's Exciting Offer: Tender for Senior Notes Unveiled
- Concord Medical Submits Annual Report for Fiscal Year 2024
- BankFirst Capital Corporation Posts Strong Q1 Performance
- Espire Dental Unifies Workforce at Engaging Conference Event
- Aliya Health Group Welcomes New Leaders to Enhance Care
- 17 Education & Technology Group Inc. Releases Annual Financial Report
- Kellanova Board Approves New $0.57 Dividend for Shareholders
- Exploring Christian Zionism: New Podcast Series Launches
- Graze Robotics and Invited Launch Pioneering Mowing Initiative
- Medtronic's OmniaSecure Lead Revolutionizes Cardiac Care Innovations
- Celebrate Planning with Plum Paper's Customer Appreciation Sale
- Innovative Grant Initiative to Foster Community Health Equity
- Investigating the HarborOne Bancorp and Eastern Bankshares Deal
- Celularity Faces Delisting Notice From Nasdaq Over Fees
- Paul Mueller Company Q1 Earnings Show Significant Growth
- Trillion Energy Takes Major Steps to Restructure Debt Efficiently
- Credicorp Ltd. Files Annual Report Showcasing Growth Insights
- Wheels Up's Commitment to Strategic Growth Amid NYSE Notice
- Fairfax Financial Holdings to Host Conference Call for Q1 Results
- AGF Investments Reveals New Final Distribution for ETF Holders
- Lug's Commitment to Sensory Accessibility with KultureCity Partnership
- Cadence Bank and Industry Bancshares Join Forces in Merger
- Zepp Health Corporation Announces Filing of 2024 Annual Report
- Innovative Neuro-Oncology Solutions with Dr. Neil A. Martin